For individuals with risk factors for recurrence, the CANMAT 2016 Depression guidelines recommend that treatment be extended to 2 years or more after achieving remission of symptoms. These factors include: frequent and/or recurrent episodes, severe episodes (psychosis, severe impairment, suicidality), ...
Monitor response, side e ects and adherence to • At least one ollow-up visit in rst treatment. 12 weeks o psychotherapy Assess symptoms using PHQ-9 at each visit. Goal: Full remission o symptoms (PHQ-9 < 5). Managing poor/incomplete Review treatment plan and modi y i • Treatment...
, whereas other studies found lower hippocampal volumes only in adults with an age of onset >3056 or no differences in hippocampal volume between adults with an adolescent versus adult age of onset of MDD57. Because only about half (57%) of the adolescent-onset patients had a recurrent ...
International datasets are being shared from multi-ethnic community populations, first episode and recurrent MDD, which are medication-free, in a current depressive episode with prospective longitudinal treatment outcomes and in remission. Neuroimaging data consist of de-identified, individual, structural MR...
Patients can be either first-episode or recurrent cases, and they should not have received antidepressant treatment or undergone Modified Electroconvulsive Therapy (MECT) or other physical therapies within the 2 weeks prior to inclusion. (4) Of Han ethnicity, both genders are acceptable, aged ...